Global Gene Expression Profiling of Ischemic Preconditioning in the Rat Retina
Overview
Molecular Biology
Ophthalmology
Authors
Affiliations
Purpose: To obtain and analyze the gene expression changes after ischemic preconditioning (IPC) in the rat retina.
Methods: Ischemic damage to the inner retina can be prevented by a short, non-deleterious, ischemic insult of 5 min applied 24 h preceding a full ischemic insult of 60 min; a phenomenon termed tolerance or IPC. The time course of changes in gene expression after induction of IPC was assessed by 22K oligonucleotide microarrays, followed by real-time quantitative polymerase chain reaction (qPCR) validation. Functional pathways of interest were identified by Gene Ontology-term analysis.
Results: Histology confirmed that IPC induction by 5 min of retinal ischemia results in a complete protection against the neurodegenerative effects of a 60 min ischemic period applied 24 or 48 h later. The microarray analysis revealed differential expression of 104 known genes at one or more time points between 1 h and 7 days after IPC. The group of altered genes contained a significant overrepresentation of genes involved in aminoacyl-tRNA synthetase activity (Iars, Lars, Cars, Yars, Gars, Tars), amino acid transport (Slc3a2, Slc6a6, Slc7a1, Slc38a2), regulation of transcription (including Egr1, Egr4, Nr4a1, Nr4a3, c-fos), and cell death (including Anxa1, Trib3). qPCR assays on cDNA of individual animals confirmed the microarray results.
Conclusions: Endogenous neuroprotection, provoked by ischemic preconditioning is associated with changes in transcript levels of several functionally-related groups of genes. During the time window of effective protection, transcript levels of genes encoding for aminoacyl-tRNA synthetases and for amino acid transport are reduced. These changes suggest that a reduction of translational activity may play a significant role in preconditioning-mediated neuroprotection.
Potential Roles of Nr4a3-Mediated Inflammation in Immunological and Neurological Diseases.
He S, Jiang W, Jiang B, Yu C, Zhao G, Li Y Mol Neurobiol. 2024; 61(8):5958-5973.
PMID: 38261254 DOI: 10.1007/s12035-024-03945-8.
Xiao K, Ma X, Zhong Z, Zhao Y, Chen X, Sun X Invest Ophthalmol Vis Sci. 2023; 64(7):2.
PMID: 37261387 PMC: 10241309. DOI: 10.1167/iovs.64.7.2.
Retinal Genomic Fabric Remodeling after Optic Nerve Injury.
Victorino P, Marra C, Iacobas D, Iacobas S, Spray D, Linden R Genes (Basel). 2021; 12(3).
PMID: 33799827 PMC: 7999523. DOI: 10.3390/genes12030403.
Gidday J Cond Med. 2019; 1(2):85-97.
PMID: 31423482 PMC: 6696944.
Durocher M, Ander B, Jickling G, Hamade F, Hull H, Knepp B J Neuroinflammation. 2019; 16(1):56.
PMID: 30836997 PMC: 6399982. DOI: 10.1186/s12974-019-1433-4.